TY - JOUR
T1 - A comparison of viral fitness and virulence between emergent adenovirus 14p1 and prototype adenovirus 14p strains
AU - Anderson, Benjamin D.
AU - Barr, Kelli L.
AU - Heil, Gary L.
AU - Friary, John A.
AU - Gray, Gregory C.
N1 - Funding Information:
This work was supported by the US Armed Forces Health Surveillance Center – Global Emerging Infections Surveillance Operations (grants to G.C.G) and the National Institute of Allergy and Infectious Diseases ( R01 AI053034 to G.C.G).
PY - 2012/7
Y1 - 2012/7
N2 - Background: Epidemiological studies from the last decade have suggested that the morbidity and mortality associated with a newly emergent strain of human adenovirus (HAdV-14p1) is greater than other, more prevalent, adenovirus strains. Recent molecular analysis identified very minor genetic differences in HAdV-14p1 compared to prototype HAdV-14p. No studies have evaluated how these differences may affect virulence. Objective: To compare HAdV-14p1 and HAdV-14p strains for competitive fitness and virulence. Study design: We performed in vitro and molecular assays to evaluate growth kinetics, cellular infectivity, cytotoxicity, and plaque morphology of the two strains. Results: Growth kinetic data showed no viral replication at 30 °C and minimal differences at 37 °C for both strains. Cellular infectivity data showed propagation capabilities for both strains in a diverse array of cell lines, with human lung and kidney cells having the highest propagation potential. Cytotoxicity data indicated cellular distress differences induced by both strains of virus in the first 12. h, but similar distress levels between 12 and 48. h. Plaque morphology assays showed some differences in average plaque diameter. Conclusions: These data suggest that the increase in morbidity and mortality observed in recent HAdV-14p1 infections is not due to viral growth or cellular infectivity differences from the prototypic HAdV-14 strain. While there were some statistically important differences detected between strains in cytotoxicity and plaque morphology assays, it seems more likely that other factors, such as environmental stressors, co-infections, or individual host response are likely contributing to the increase in morbidity.
AB - Background: Epidemiological studies from the last decade have suggested that the morbidity and mortality associated with a newly emergent strain of human adenovirus (HAdV-14p1) is greater than other, more prevalent, adenovirus strains. Recent molecular analysis identified very minor genetic differences in HAdV-14p1 compared to prototype HAdV-14p. No studies have evaluated how these differences may affect virulence. Objective: To compare HAdV-14p1 and HAdV-14p strains for competitive fitness and virulence. Study design: We performed in vitro and molecular assays to evaluate growth kinetics, cellular infectivity, cytotoxicity, and plaque morphology of the two strains. Results: Growth kinetic data showed no viral replication at 30 °C and minimal differences at 37 °C for both strains. Cellular infectivity data showed propagation capabilities for both strains in a diverse array of cell lines, with human lung and kidney cells having the highest propagation potential. Cytotoxicity data indicated cellular distress differences induced by both strains of virus in the first 12. h, but similar distress levels between 12 and 48. h. Plaque morphology assays showed some differences in average plaque diameter. Conclusions: These data suggest that the increase in morbidity and mortality observed in recent HAdV-14p1 infections is not due to viral growth or cellular infectivity differences from the prototypic HAdV-14 strain. While there were some statistically important differences detected between strains in cytotoxicity and plaque morphology assays, it seems more likely that other factors, such as environmental stressors, co-infections, or individual host response are likely contributing to the increase in morbidity.
KW - Adenoviruses
KW - Viral diseases
KW - Virology
KW - Virulence
UR - http://www.scopus.com/inward/record.url?scp=84861687452&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84861687452&partnerID=8YFLogxK
U2 - 10.1016/j.jcv.2012.03.006
DO - 10.1016/j.jcv.2012.03.006
M3 - Article
C2 - 22484030
AN - SCOPUS:84861687452
SN - 1386-6532
VL - 54
SP - 265
EP - 268
JO - Journal of Clinical Virology
JF - Journal of Clinical Virology
IS - 3
ER -